Status:
TERMINATED
Incremental Cost-Utility Study on Prehabilitation Among Older Patients With Colorectal Cancer Undergoing Surgery
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Leading the Change: Collaboration of health Insurers in the Netherlands
Conditions:
Colorectal Cancer
Surgery
Eligibility:
All Genders
Brief Summary
A prospective multicenter observational cost-utility study following older or high-risk patients with colorectal cancer with and without prehabilitation before surgery.
Detailed Description
This study will answer the question whether prehabilitation is cost-effective in colorectal cancer surgery among individual patients aged 70 years and above or patients with an American Society of Ane...
Eligibility Criteria
Inclusion
- Age ≥ 70 years or American Society of Anesthesiologists (ASA) score of III
- Scheduled for colorectal cancer surgery
Exclusion
- Metastatic disease known preoperatively
- ASA IV score or higher
- Paralytic or immobilized patients (not capable to perform exercise)
- Prior use of neoadjuvant therapy for the same indication
- Not able or willing to provide written informed consent
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04097795
Start Date
July 1 2019
End Date
December 31 2021
Last Update
December 18 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, Netherlands
2
Noordwest Ziekenhuisgroep
Alkmaar, Netherlands
3
Ziekenhuisgroep Twente
Almelo, Netherlands
4
Radboudumc
Nijmegen, Netherlands